Lead the team providing project and program management, portfolio prioritization and planning, and alliance management for Erasca's portfolio of oncology therapeutics targeting the RAS/RAF/MEK/MAPK pathway.Served as Program Team Lead for ERAS-007, our proprietary ERK inhibitor. Program focuses on mono therapy and combination therapy clinical studies in solid tumors including NSCLC, CRC, and PDAC tumors. Program includes Clinical Trial Collaboration and Supply Agreements with Pfizer and Lilly.Serve as Program Team Lead for pan-RAF inhibitor Naporafenib being developed for solid tumors containing mutations in the RAS/RAF/MEK/MAPK pathway. SEACRAFT-1 Phase 1 study actively recruiting patients with solid tumors containing confirmed RAS mutations at codon 61 (RAS Q61X).

Global Program Management Lead for Bempegaldesleukin (NKTR-214) program, an immuno-modulating therapy of recombinant human Interleukin-2 for solid tumor indications including melanoma, bladder, kidney, lung, breast, pancreatic, and squamous cell carcinoma. Bempeg is also being studied in SARS-COV-2 infected patients.• Program management lead for program strategy and execution including:o 2 Phase 1 dose optimization oncology studies with Phase 2 dose expansion armso 1 Phase 1 COVID-19 studyo 1 Phase 2 oncology registrational studyo 4 Phase 3 oncology registrational studieso 10 joint partnership studies of various phases involving combination therapies with checkpoint inhibitor, chemotherapy, and cancer vaccine therapies• Serve as a single point of contact on program details for executive and functional management• Responsible for program management of clinical and development milestones and deliverables• Manage the Development Product and Strategy Teams in the generation and maintenance of cross-functional development plans, study designs, and lifecycle strategy.• Facilitate Core and Extended Teams and present for decision making at governance bodies.• Work closely with and drive collaboration and transparency across all company functions including clinical, drug safety, clinical operations, clinical pharmacology, biostatistics, translational medicine, toxicology, CMC/manufacturing, drug supply, medical affairs, marketing, finance, accounting, and commercialization teams.• Ensure potential risks are identified and contingency plans are in place• Ensure joint partnerships and resources are leveraged effectively, and with accountability, to achieve cross-company objectives.• Resolve conflicts at the individual and team levels, develop and maintain high performing teams and, if necessary, escalate performance issues to functional management• Manage a team of 4 direct reports (project managers)

DeviceFarm is creating a medical device to cure toenail fungal infections by allowing a doctor to fumigate the nail with plasma gas because gas can penetrate the nail and kill the underlying fungus where liquids, creams, and lasers cannot reach. Unlike oral treatments that can damage your liver, the topical gas treatment is safe, easy, and convenient for both the doctor and the patient.• Awarded $150K National Science Foundation (NSF) SBIR Phase I grant• Awarded $150K National Institute of Health (NIH) SBIR Phase I grant• Faculty Choice Award winner of 2015 UC Berkeley LAUNCH Accelerator Program• Awarded $900K in National Science Foundation (NSF) SBIR Phase II grants• Awarded $1.4M National Institute of Health (NIH) SBIR Phase II grant• Granted 2 US Patents

Assised a clinical stage biotechnology company in the immuno-oncology space develop an autologous cell therapy for solid tumor cancers. Develop project plans and coordinate activities for process development, facility construction, and validation for clinical enabling cell manufacturing.

Program leader, project manager, and subject matter expert supporting life science product development, technical operations, compliance, and business process improvement projects. Expert in project change management and communications.Led and supported pharmaceutical, biotechnology, diagnostic, and medical device project teams.• Managed global filing team of over 60 people for a joint hematological oncology development project between two major pharmaceutical companies. Accountable for planning, tracking and coordinating FDA and EMA supplemental New Drug Application (sNDA) activities and resources targeting indications for chronic lymphocytic leukemia (CLL) in collaboration with senior management from both companies. Led joint filing team meetings across both companies. Responsible for optimizing timelines, filing scenarios, communications, and project execution.• Supported a mid-sized pharmaceutical company's first compassionate use clinical program that activated 92 clinical sites and enrolled 1600 patients in six months. Facilitated Project Core Team meetings and discussions. Assisted Medical and Clinical Leads for all project status updates and communications to Executive Management on this highly visible and critical project.• Managed a team for a major pharmaceutical division that created document management processes required for chemistry, manufacturing, and controls (CMC) regulatory documents for product applications to the FDA and other regulatory agencies.• Facilitated business process improvement activities of a Clinical Development group for a mid-sized pharmaceutical company experiencing rapid growth and organizational changes. Mapped the processes and proposed improvements to the Medical Writing team. Created dashboards and led planning meetings for the Publications teams. Designed and assisted the implementation of Medical Affairs and Scientific Affairs document review processes and communications.

Founders Network is a private community of tech startup founders committed to helping each other succeed through peer mentorship. Members gain a support network featuring peer advice based on experience and personal introductions to key individuals like investors, customers and vetted service providers. The benefits are faster, smarter decision making; increased access to growth opportunities; and peace of mind from minimizing personal and management risk.

Managed all operations, quality control, order fulfillment, customer service, and social media marketing for consumer product startup company.• Expanded operations from US to New Zealand and Australia with a team of 28 sales consultants.• Dominated company search engine results by leveraging social media and search engine optimization strategies.

Led strategic projects for pharmaceutical, biotechnology, medical device, and medical diagnostics companies.• Achieved >600% revenue growth year-over-year managing a cross-functional program to drive commercial growth in Brazil, Russia, India, and China for a global diagnostics business. • Completed 30+ projects in 28 countries including marketing evaluations, clinical trials, and product regulatory approvals by leading a global diagnostic product registration program.• Developed and gained senior management approval for a major pharmaceutical division's document management processes required for electronic submission of product applications to the FDA and European regulatory bodies.• Enabled an on-schedule launch of a drug:device combination product by rescuing a project plan and schedule for a complaint handling and investigation process for that had suffered delays and internal set backs. • Gained consensus from Senior Management, Key Opinion Leaders, and corporate partners on a project plan, budget, and schedule for an international pharmaceutical partnership to develop new infectious disease medications.

Managed large genome-wide association studies to identify genetic loci linked to common human diseases and responses to medication. Supervised 20+ research associates on high-throughput single nucleotide polymorphism (SNP) genotyping projects.• Led two of the company’s largest multi-million dollar projects within first six months of employment and achieved the highest level of quality metrics of any large project.• Increased lab capacity 150% from 200 to 500 genotyping chips/day by enhancing workflows, SOPs, and data analysis.

Managed team of 55 undergraduates and 5 technicians to develop the first amphibian genetic animal model. Pioneered Xenopus tropicalis genetics and genomics research covering a wide variety of areas including genome sequencing and annotation, cDNA library construction, EST sequencing projects, histological techniques, gene expression assays, animal husbandry, veterinary medicine, and forward genetic screens using radiation, chemical, and insertional mutagenesis strategies.• Published 10 papers in leading peer-reviewed scientific journals.• Won 19 fellowship and scholarship awards for the program.

Studied the regulation of stem cell differentiation, tissue formation, and organogenesis in the Xenopus laevis frog embryo.• Published 2 papers in prestigious peer-reviewed scientific journals.• Awarded a fellowship from the Leukemia and Lymphoma Society of America.

Studied the regulation of two major pathways (PI3K/mTOR and Ras/Raf/MAPK) involved in normal and pathogenic cell proliferation and differentiation. Expert in tissue culture, protein purification, cell-based assays, and in vitro biochemical assays.• Published 12 manuscripts and book chapters.